Journal of International Oncology››2016,Vol. 43››Issue (2): 130-.
Previous ArticlesNext Articles
CHEN Zhi-Da, ZENG Wen-Rong, LIN Bin, WU Xin-Yu, WU Jin
Online:
2016-02-08Published:
2015-12-28CHEN Zhi-Da, ZENG Wen-Rong, LIN Bin, WU Xin-Yu, WU Jin. Voltagegated potassium channel Kv1.5 and cancer[J]. Journal of International Oncology, 2016, 43(2): 130-.
013, 4:283. DOI:10.3389/fphys.2013.00283. [13] Bielanska J, HernandezLosa J, Moline T, et al. Differential expression of Kv1.3 and Kv1.5 voltagedependent K+ channels in human skeletal muscle sarcomas[J]. Cancer Invest, 2012, 30(3):203208. DOI:10.3109/07357907.2012.654872. [14] Zhanping W, Xiaoyu P, Na C, et al. Voltagegated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell[J]. Gynecol Oncol, 2007, 104(2):455460. DOI:10.1016/j.ygyno.2006.08.033. [15] Lan M, Shi Y, Han Z, et al. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells[J]. Cancer Biol Ther, 2005, 4(12):13421347. DOI:10.1096/fj.066200com. [16] Spitzner M, Ousingsawat J, Scheidt K, et al. Voltagegated K+ channels support proliferation of colonic carcinoma cells[J]. FASEB J, 2007, 21(1):3544. [17] Lang F, Fller M, Lang KS, et al. Ion channels in cell proliferation and apoptotic cell death[J]. J Membr Biol, 2005, 205(3):147157. DOI:10.1007/s0023200507805. [18] Bonnet S, Archer S L, AllalunisTurner J, et al. A mitochondriaK+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth[J]. Cancer Cell, 2007, 11(1):3751. DOI:10.1016/j.ccr.2006.10.020. [19] Sutendra G, Bonnet S, Rochefort G, et al. Fatty acid oxidation and malonylCoA decarboxylase in the vascular remodeling of pulmonary hypertension[J]. Sci Transl Med, 2010, 2(44):44r58r. DOI:10.1126/scitranslmed.3001327. [20] Arvind S, Arivazhagan A, Santosh V, et al. Differential expression of a novel voltage gated potassium channel—Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma[J]. Br J Neurosurg, 2012, 26(1):1620. DOI:10.3109/02688697.2011.583365. [21] Preussat K, Beetz C, Schrey M, et al. Expression of voltagegated potassium channels Kv1.3 and Kv1.5 in human gliomas[J]. Neurosci Lett, 2003, 346(12):3336. [22] Ralph SJ, RodriguezEnriquez S, Neuzil J, et al. The causes of cancer revisited: "mitochondrial malignancy" and ROSinduced oncogenic transformationwhy mitochondria are targets for cancer therapy[J]. Mol Aspects Med, 2010, 31(2):145170. DOI:10.1016/j.mam.2010.02.008. [23] Wong JY, Huggins GS, Debidda M, et al. Dichloroacetate induces apoptosis in endometrial cancer cells[J]. Gynecol Oncol, 2008, 109(3):394402. DOI:10.1016/j.ygyno.2008.01.038. [24] Xie J, Wang BS, Yu DH, et al. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells[J]. Int J Oncol, 2011, 38(2):409417. DOI:10.3892/ijo.2010.851. [25] El Gebeily G, Fiset C. Upregulation of ventricular potassium channels by chronic tamoxifen treatment[J]. Cardiovasc Res, 2011, 90(1):6876. DOI:10.1093/cvr/cvq384. [26] Yang L, Ma JH, Zhang PH, et al. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment[J]. Clin Exp Pharmacol Physiol, 2009, 36(2):154161. 10.1111/j.14401681.2008.05061.x. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||